logo
  

Goldman Sachs CFO Stephen Scherr To Retire; Names Denis Coleman CFO

Goldman Sachs Group Inc. (GS) said Tuesday that its Chief Financial Officer Stephen Scherr has decided to retire from the firm. Denis Coleman III, co-head of the Global Financing Group, will become the firm's Chief Financial Officer, effective January 1, 2022.

After a distinguished career at Goldman Sachs spanning three decades, including serving for the last three years as Chief Financial Officer, Stephen Scherr has decided to retire from the firm. Stephen will remain Chief Financial Officer until the end of the year and will retire from the firm at the end of January. Upon his retirement, he will become a Senior Director.

The company noted that Denis will serve as Deputy Chief Financial Officer effective immediately to ensure a smooth transition.

Denis has served as co-head of the Global Financing Group in the Investment Banking Division since 2018.

Denis joined Goldman Sachs in 1996 as an analyst in the Bank Loan Group. In 1998, he moved to Capital Markets in the then Fixed Income, Currency and Commodities Division. He transferred to the Investment Banking Division in 2004 and became co-head of U.S. Loan Capital Markets in 2005.

In 2008, Denis was named co-head of U.S. Leveraged Finance, in 2009 he became head of EMEA Credit Finance in London and was then named head of the EMEA Financing Group from 2016 to June 2018. Denis was named managing director in 2005 and partner in 2008.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT